THRX

Theravance, Inc. News Headlines

$15.25
*  
0.07
0.46%
Get THRX Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading THRX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seth Klarman's Top Stock Picks
2/20/2013 7:21:00 PM - Seeking Alpha


Upcoming FDA Approval Decision Dates For Q2 2013
2/15/2013 1:43:00 PM - Seeking Alpha


Theravance, Inc. Has Upcoming Catalysts And Long-Term Potential
2/14/2013 4:10:00 PM - Seeking Alpha


Tracking Seth Klarman's Baupost Group Holdings - Q4 2012 Update
2/14/2013 3:58:00 AM - Seeking Alpha


Seth Klarman's Baupost Group Buys AIG, Idenix Pharmaceuticals, Sells Hewlett-Packard, Oracle, ...
2/13/2013 6:44:46 PM - GuruFocus


Theravance Narrows Y/Y Loss - Analyst Blog
2/13/2013 9:41:01 AM - Zacks.com


2 Biotech Stocks With Upcoming Catalysts
2/4/2013 7:54:00 PM - Seeking Alpha


Theravance Winds up Public Offering - Analyst Blog
1/28/2013 9:10:01 AM - Zacks.com


Theravance to Offer Notes - Analyst Blog
1/17/2013 12:00:01 PM - Zacks.com


Glaxo/THRX Seek European Approval - Analyst Blog
1/10/2013 12:50:01 PM - Zacks.com


Theravance: Temping To Investors As Well As Partners
1/8/2013 5:28:00 PM - Seeking Alpha


Insiders Love These 3 Highly Shorted Biotech Stocks
1/8/2013 2:13:00 AM - Seeking Alpha


Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN
1/7/2013 11:04:47 AM - GuruFocus


Glaxo's Influenza Vaccine Approved - Analyst Blog
12/24/2012 3:00:01 PM - Zacks.com


Glaxo/Amicus' Fabry Drug Disappoints - Analyst Blog
12/21/2012 12:14:01 PM - Zacks.com


Glaxo/THRX's COPD Candidate Advances - Analyst Blog
12/20/2012 9:50:01 AM - Zacks.com


Pipeline Progress at Theravance - Analyst Blog
12/5/2012 8:20:01 AM - Zacks.com


Glaxo Invests in Nigeria - Analyst Blog
11/28/2012 8:10:01 AM - Zacks.com


Glaxo to Expand in India - Analyst Blog
11/27/2012 2:45:01 PM - Zacks.com


Wednesday's Bio-Pharma Catalyst Trades And Watch List
11/21/2012 7:50:00 AM - Seeking Alpha


Glaxo's Promacta Label Expanded - Analyst Blog
11/20/2012 11:20:01 AM - Zacks.com


Tracking Seth Klarman's Baupost Group Holdings - Q3 2012 Update
11/14/2012 4:57:00 AM - Seeking Alpha


Promising Biotech Stocks With Upcoming FDA Catalysts
11/13/2012 10:52:00 AM - Seeking Alpha


For NovaBay, Simplicity Is The Father Of Invention
11/12/2012 9:23:00 AM - Seeking Alpha


Theravance: Still A Buy On Weakness
11/4/2012 6:03:00 AM - Seeking Alpha